首页> 美国卫生研究院文献>Journal of Clinical Oncology >Risk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma: The Stanford University Experience Over Three Generations of Clinical Trials

【2h】

Risk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma: The Stanford University Experience Over Three Generations of Clinical Trials

机译：霍奇金淋巴瘤中与治疗有关的继发性白血病的风险：斯坦福大学经历三代临床试验的经验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo assess therapy-related acute myeloid leukemia/myelodysplastic syndrome (t-AML/MDS) risk in patients treated for Hodgkin lymphoma (HL) on successive generations of Stanford clinical trials.

机译：目的在连续几代的斯坦福大学临床试验中，评估接受霍奇金淋巴瘤（HL）治疗的患者与治疗相关的急性髓细胞性白血病/骨髓增生异常综合症（t-AML / MDS）的风险。

著录项

期刊名称 Journal of Clinical Oncology
作者
Michael Zach Koontz; Sandra J. Horning; Raymond Balise; Peter L. Greenberg; Saul A. Rosenberg; Richard T. Hoppe; Ranjana H. Advani;
展开▼
作者单位

展开▼
年(卷),期 -1(31),5
年度 -1
页码 592–598
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 德国霍奇金淋巴瘤研究小组报告:原发性霍奇金病继发非霍奇金淋巴瘤的发病率、治疗及预后 [J] . U.Rueffer, 张玉平, 等中德临床肿瘤学杂志（英文版） . 2001,第006期
2. Risk of therapy-related secondary leukemia in hodgkin lymphoma: the stanford university experience over three generations of clinical trials. [J] . Michael Zach Koontz, Sandra J Horning, Raymond Balise, Journal of Clinical Oncology . 2013,第5期

机译：霍奇金淋巴瘤中与治疗有关的继发性白血病的风险：斯坦福大学在三代临床试验中的经验。
3. Risk of therapy-related secondary leukemia in hodgkin lymphoma: the stanford university experience over three generations of clinical trials. [J] . Michael Zach Koontz, Sandra J Horning, Raymond Balise, Journal of Clinical Oncology . 2013,第5期

机译：Hodgkin淋巴瘤治疗相关二次白血病风险：斯坦福大学在三代临床试验中的经验。
4. Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma. [J] . Lillington DM, Micallef IN, Carpenter E, Journal of Clinical Oncology . 2001,第9期

机译：非霍奇金淋巴瘤治疗后发展为治疗相关性骨髓增生异常和继发性急性骨髓性白血病的患者大剂量治疗前染色体异常的检测。
5. CLINICAL ADVANCEMENT OF A RNA-TRANSFECTED CD40-B CELL VACCINE FOR THE TREATMENT OF CANINE NON-HODGKIN'S LYMPHOMA [C] . Nicola Mason, Martha MalonevHuss, Josephine Gnanandarajah Conference of the American^College^of^Veterinary^Internal^Medicine . 2016

机译：RNA转染的CD40-B细胞疫苗治疗犬非霍奇金淋巴瘤的临床进展
6. Action of topoisomerase targeting drugs on Non-Hodgkin's lymphoma and leukemia: Correlation of clinical and cell culture studies. [D] . Nair, Jayasree S. 2000

机译：拓扑异构酶靶向药物对非霍奇金淋巴瘤和白血病的作用：临床和细胞培养研究的相关性。
7. Clinical Trials and ObservationsLymphoid Neoplasia: Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951 [O] . Barbara De Moerloose, Stefan Suciu, Yves Bertrand, -1

机译：临床试验和观察淋巴瘤样增生：长春新碱和皮质类固醇激素脉冲持续治疗儿童平均风险的急性危险性淋巴母细胞白血病（ALL）和淋巴母细胞非霍奇金淋巴瘤（NHL）继续治疗：EORTC 3期随机试验的报告58951
8. Outcome of Tandem Autologous/Allogeneic Hematopoietic Cell Transplantation in High-Risk Non Hodgkin's Lymphoma Patients: Stanford University Experience [O] . Wudhikarn Kitsada, Lavori Philip, Arai Sally, 2014

机译：高危非霍奇金淋巴瘤患者串联自体/同种异体造血细胞移植的结果：斯坦福大学的经验

Risk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma: The Stanford University Experience Over Three Generations of Clinical Trials

摘要

著录项

相似文献

相关主题

期刊订阅